[1] | Budastsa IN, Arhana BN, Mudita IB. Plasma prothrombin time and activated partial thromboplastin time as predictors of bleeding manifestations during fengue hemorrhagic fever. Peadiatr Indones. 2009; 49(2): 69-4. |
|
[2] | Mackenzie JS, Gubler DJ, Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis. West Nile and dengue viruses. Nat Med. 2004, 10 (12 Suppl):S 98-S109. |
|
[3] | Chuang YC, Lin YS, Liu CC, Liu HS, Liao SH, Shi MD, Lei HY, Yeh TM. Factors contributing to the disturbance of coagulation and fibrinolysis in dengue virus infection. J Formos Med Assoc. 2013; 112(1): 12-7. |
|
[4] | Hyams KC, Oldfield EC, Scott RM, Bourgeois AL, Gardiner H, Pazzaglia G et al. Evaluation of febrile patients in Port Sudan, Sudan: isolation of dengue virus. Am J Trop Med Hyg. 1986; 35 (4): 860-5 |
|
[5] | Malik A, Earhat K, Mohareb E, Saad M, Saeed M et al. Dengue hemorrhagic fever outbreak in children in Port Sudan. J Infect Public Health. 2011; 4 (1): 1-6. |
|
[6] | Ali KA, Abu elgasim S. A correlation study between clinical manifestation of dengue fever and degree of liver injury. J Microbiol Antimicrob. 2012; 4 (2): 45-48. |
|
[7] | Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, Chau NV et al. Coagulation abnormalities in dengue hemorrhagic fever: serial investigation in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis. 2002; 35 (3): 277-85. |
|
[8] | Huang YH, Liu CC, Wang ST, Lei HY, Liu HL, Lin YS, et al. Activation of coagulation and fibrinolysis during dengue virus infection. J Med Virol. 2001; 63(3): 247-51. |
|
[9] | Mairuhu A, Setiati T, Koraka P, Hack C, Leyte A, Faradz S, et al. Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism. Thromb J. 2005; 3:17. |
|
[10] | Phuong CT, Nhan NT, Thuy PTT, Thein CV, Nga NTT, Thuy TT et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is World Health Organization Classification system help?. Am J Trop Med Hyg; 2004: 70 (2): 172-9. |
|
[11] | Guzman MG, Kouri G. Dengue: an update. Lancet. 2002; 2(1): 33-2. |
|
[12] | Nimmannitya S. Dengue Hemorrhagic Fever: Disorder of hemostasis. Bangkok J Pediatrics. 1999; 24: 184-7. |
|
[13] | Lin SW, Chuang YC, Lin YS, Lei HY, Liu HS, Yeh TM. Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation. J Infect.2012; 64:325-34. |
|
[14] | Wills B et al. Hemostatic change in Vietnams children with mild dengue correlate with the severity of vascular leakage rather than bleeding. Am J Trop Med Hyg. 2009; 81(4): 638-44. |
|
[15] | Chuang YC, Lin YC, Liu HS, Wang JR, Yeh TM. Antibodies against thrombin in dengue patient contain both anti-thrombotic and pro-fibrinolytic activities. Thromb Haemost. 2013; 110 (2): 358-65. |
|
[16] | Chuansumrit A, Tangnararatchakit K. Pathophysiology and management of dengue hemorrhagic fever. Journal Compilation Transfusion Alternatives in Transfusion Medicine. 2006; 8 (Suppl.1): 3-11. |
|
[17] | Krishnamueit C, Kalaynarooj S, Cutting MA, Peat RA, Rothwell AW, Reid TJ et al. Mechanism of hemorrhage in dengue without circulatory collapse. Am Trop Med Hyg. 2001; 65(6): 840-7. |
|
[18] | Liu JW, Khor BS, Lee CH, Lee IK, Chen RF, Yang KD. Dengue hemorrhagic fever in Taiwan. Dengue Bulletin. 2003; 27: 19-24. |
|